OFFICIAL PUBLICATION OF

by its subsidiary APPco

PDL Practice Alert

Chris Brooker 03/03/2016

Important changes to legislation regarding pseudoephedrine and naloxone On February 1, 2016, the scheduling on Naloxone changed from S4 to S3 for the treatment of opioid overdose. The two current suppliers of Naloxone have to this date not provided S3 packs so this means pharmacists supplying the product need to be aware of several factors

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Teal questions pharmacist UTI programs

because much of the time, I think they’re giving antibiotics for things that are not UTIsPolitician says "I think" and…

Michael Hewson

Medics to ‘fight’ Doctor of Pharmacy title

Yet right now there are far too many reports from overseas of patients being unsure whether their care is from…

Michael Hewson

In scarce supply

I love a good joke.

Evan Nickols

Concurrent funding for aged care pharmacists and RMMRs needed

I understood that was to happen as a gradual changeover and not an abrupt cessation. Currently we do not have…

Jenny Gowan

PDL Practice Alert

Previous Northern flu season a sign for Australia: Terry White Group

Next Clinical tips: osteoarthritis

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

Hyperpigmentation

MENU

Previous Northern flu season a sign for Australia: Terry White Group

Next Clinical tips: osteoarthritis

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.